Context-dependent immunogenicity of an S206G-substituted H-2Db- restricted simian virus 40 large T antigen epitope I variant

Journal of Immunology

Volumn 162, Issue 4, 1999, Pages 2171-2179

  Mylin, Lawrence M ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; VIRUS LARGE T ANTIGEN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EPITOPE MAPPING; IMMUNIZATION; IMMUNOGENICITY; MALE; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SIMIAN VIRUS 40;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL, TUMOR; CLONE CELLS; EPITOPES, T-LYMPHOCYTE; GLYCINE; H-2 ANTIGENS; MALE; MICE; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; SERINE; SIMIAN VIRUS 40; T-LYMPHOCYTES; VARIATION (GENETICS);

EID: 0033558053     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Yewdell, J. W., and J. R. Bennink. 1992. Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv. Immunol. 52:1.
2. Germain, R. N., and D. H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403.
3. Vinitsky, A., L. C. Anton, H. L. Snyder, M. Orlowski, J. R. Bennink, and J. W. Yewdell. 1997. The generation of MHC class I-associated peptides is only partially inhibited by proteasome inhibitors. J. Immunol. 159:554.
4. York, I. A., and K. L. Rock. 1996. Antigen processing and presentation by the class I major histocompatibility complex. Annu. Rev. Immunol. 14:369.
5. Heemels, M. T., and H. Ploegh. 1995. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu. Rev. Biochem. 64:463.
6. b-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen. J. Virol. 69:3134.
7. + T cell recognition of an endogenously processed epitope is regulated primarily by residues within the epitope. J. Exp. Med. 176:1335.
8. Hahn, Y. S., V. L. Braciale, and T. J. Braciale. 1991. Presentation of viral antigen to class I major histocompatibility complex-restricted cytotoxic T lymphocyte: recognition of an immunodominant influenza hemagglutinin site by cytotoxic T lymphocyte is independent of the position of the site in the hemagglutinin translation product. J. Exp. Med. 174:733.
9. Fu, T.-M., L. M. Mylin, T. D. Schell, I. Bacik, G. Russ, J. W. Yewdell, J. R. Bennink, and S. S. Tevethia. 1998. An endoplasmic reticulum targeting signal sequence enhances the immunogenicity of an immunorecessive simian virus 40 T antigen cytotoxic T lymphocyte epitope. J. Virol. 72:1469.
10. Fu, T.-M., R. H. Bonneau, M. J. Tevethia, and S. S. Tevethia. 1993. Simian virus 40 T antigen as a carrier for the expression of cytotoxic T-lymphocyte recognition epitopes. J. Virol. 67:6866.
11. Chimini, G., P. Pala, J. Sire, J. B. R., and J. L. Maryanski. 1989. Recognition of oligonucleotide-encoded T cell epitopes introduced into a gene unrelated to the original antigen. J. Exp. Med. 169:297.
12. Del Val, M., H. J. Schlicht, T. Ruppert, M. J. Reddehase, and U. H. Koszinowski. 1991. Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein. Cell 66: 1145.
13. Bergmann, C. C., L. Tong, R. Cua, J. Sensintaffar, and S. Stohlman. 1994. Differential effects of flanking residues on presentation of epitopes from chimeric peptides. J. Virol. 68:5306.
14. Bergmann, C. C., Q. Yao, C-K. Ho, and S. L. Buckwold. 1996. Flanking residues alter antigenicity and immunogenicity of multi-unit CTL epitopes. J. Immunol. 157:3242.
15. b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen. J. Virol. 69:6665.
16. Yellen-Shaw, A. J., E. J. Wherry, G. C. Dubois, and L. C. Eisenlohr. 1997. Point mutation flanking a CTL epitope ablates in vitro and in vivo recognition of a full-length viral protein. J. Immunol. 158:3227.
17. Yellen-Shaw, A. J., and L. C. Eisenlohr. 1997. Regulation of class I-restricted epitope processing by local or distal flanking residues. J. Immunol. 158:1727.
18. Couillin, I., B. Culmann-Penciolelli, E. Gomard, J. Choppin, J.-P. Levy, J.-G. Guillet, and S. Saragosti. 1994. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. J. Exp. Med. 180:1129.
19. Shastri, N., T. Serwold, and F. Gonzalez. 1995. Presentation of endogenous peptide/MHC class I complexes is profoundly influenced by specific C-terminal flanking residues. J. Immunol. 155:4339.
20. Tevethia, S. S., M. Lewis, Y. Tanaka, J. Milici, B. B. Knowles, W. L. Maloy, and R. Anderson. 1990. Dissection of H-2Db-restricted cytotoxic T-lymphocyte epitopes on simian virus 40 T antigen by the use of synthetic peptides and H-2Dbm mutants. J. Virol. 64:1192.
21. Tevethia, S. S. 1990. Recognition of simian virus 40 T antigen by cytotoxic T lymphocytes. Mol. Biol. Med. 7:83.
22. Tevethia, S. S. 1980. Immunology of simian virus 40. In Viral Oncology. G. Klein, ed. Raven Press, New York. p. 581.
23. b-restricted cytotoxic T-lymphocyte clones and a synthetic peptide. Virology 171:205.
24. Tanaka, Y., M. J. Tevethia, D. Kalderon, A. E. Smith, and S. S. Tevethia. 1988. Clustering of antigenic sites recognized by cytotoxic T lymphocyte clones in the amino terminal half of SV40 T antigen. Virology 162:427.
25. b-restricted cytotoxic T-lymphocyte recognition epitopes in simian virus 40 T antigen. J. Virol. 66:440.
26. Tooze, J. 1980. DNA Tumor Viruses: Molecular Biology of Tumor Viruses. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
27. Tevethia, S. S., R. S. Greenfield, D. C. Flyer, and M. J. Tevethia. 1980. SV40 transplantation antigen: relationship to SV40-specific proteins. Cold Spring Harbor Symp. Quant. Biol. 1:235.
28. Tanaka, Y., and S. S. Tevethia. 1990. Loss of immunorecessive cytotoxic T lymphocyte determinant V on SV40 T antigen following cocultivation with site-specific cytotoxic T lymphocyte clone Y-5. Intervirology 31:197.
29. Tanaka, Y., and S. S. Tevethia. 1988. In vitro selection of SV40 T antigen epitope loss variants by site-specific cytotoxic T lymphocyte clones. J. Immunol. 140: 4348.
30. Lill, N. L., M. J. Tevethia, W.G. Hendrickson, and S. S. Tevethia. 1992. Cytotoxic T lymphocytes (CTL) against a transforming gene product select for transformed cells with point mutations within sequences encoding CTL recognition epitopes. J. Exp. Med. 176:449.
31. b-restricted determinant in simian virus 40 tumor antigen. Virology 208:159.
32. Tevethia, M. J. 1984. Immortalization of primary mouse embryo fibroblasts with SV40 virions, viral DNA, and a subgenomic DNA fragment in a quantitative assay. Virology 137:414.
33. Campbell, A. E., F. L. Foley, and S. S. Tevethia. 1983. Demonstration of multiple antigenic sites of the SV40 transplantation rejection antigen by using cyloloxic T lymphocyte clones. J. Immunol. 130:490.
34. b-restricted epitopes, on antigen presentation and recognition by cytotoxic T lymphocyte clones. J. Immunol. 148:3012.
35. Ljunggren, H. G., and K. Kärre. 1985. Host resistance directed selectively against H-2-deficient lymphoma variants: analysis of the mechanism. J. Exp. Med. 162: 1745.
36. Kärre, K., H. G. Ljunggren, G. Piontek, and R. Kiessling. 1986. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319:675.
37. Ljunggren, H. G., N. J. Stam, C. Ohlen, J. J. Neefjes, P. Hoglund, M. T. Heemels, J. Bastin, T. N. Schumacher, A. Townsend, and K. Karre. 1990. Empty MHC class I molecules come out in the cold. Nature 346:476.
38. Townsend, A., C. Ohlen, J. Bastin, H. G. Ljunggren, L. Foster, and K. Karre. 1989. Association of class I major histocompatibility heavy and light chains induced by viral peptides. Nature 340:443.
39. Townsend, A., T. Elliott, V. Cerundolo, L. Foster, B. Barber, and A. Tse. 1990. Assembly of MHC class I molecules analyzed in vitro. Cell 62:285.
40. 2 microglobulin. J. Exp. Med. 160:317.
41. Driscoll, J., M. G. Brown, D. Finley, and J. J. Monaco. 1993. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 365:262.
42. Dick, L. R., C. Adlrich, S. C. Jameson, C. R. Moomaw, B. C. Pramanik, C. K. Doyle, G. N. DeMartino, M. J. Bevan, J. M. Forman, and C. A. Slaughter. 1994. Proteolytic processing of ovalbumin and β-galactosidase by the proteasome to yield antigenic peptides. J. Immunol. 152:3884.
43. Eggers, M., B. Boes-Fabian, T. Ruppert, P.-M. Kloetzel, and U. H. Koszinowski. 1995. The cleavage preference of the proteasome governs the yield of antigenic peptides. J. Exp. Med. 182:1865.
44. Eisenlohr, L. C., J. W. Yewdell, and J. R. Bennink. 1992. Flanking sequences influence the presentation of an endogenously synthesized peptide to cytotoxic T lymphocytes. J. Exp. Med. 175:481.
45. d-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection. Virology 244:427.
46. Ossendorp, F., M. Eggers, A. Neisig, T. Ruppert, M. Groettrup, A. Sijts, E. Mengedé, P.-M. Kloetzel, J. Neefjes, U. Koszinowski, et al. 1996. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 5:115.
47. Niedermann, G., S. Butz, H. G. Ihlenfeldt, R. Grimm, M. Lucchiari, H. Hoschutzky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2:289.
48. Gooding, L. R., and C. B. Edwards. 1980. H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes. J. Immunol. 124:1258.
49. Bevan, M. J. 1976. Cross-priming for a secondary cytotoxic response to minor H-antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143:1283.
50. Bevan, M. J. 1995. Antigen presentation to cytotoxic T lymphocytes in vivo. J. Exp. Med. 182:639.
51. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
52. Albert, M. L., B. Sauter, and N. Bhardwaj. 1998. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392:86.